Patents Represented by Attorney Jason I. Garbell
  • Patent number: 8202986
    Abstract: A branched hyaluronic acid, wherein the linear backbone comprises hyaluronic acid in which one or more N-Acetyl-Glucosamine has been deacetylated to Glucosamine, with branching sidechain(s) covalently linked to the primary amine(s) of said deacetylated Glucosamine thus forming a secondary amine(s); a precursor for producing said branched hyaluronic acid; and a method for producing said branching hyaluronic acid.
    Type: Grant
    Filed: July 13, 2007
    Date of Patent: June 19, 2012
    Assignee: Novozymes Biopolymer AIS
    Inventors: Kristoffer Toemmeraas, Khadija Schwach-Abdellaoui
  • Patent number: 7378264
    Abstract: The present invention relates to a method of constructing a variant of a parent Termamyl-like ?-amylase, which variant has ?-amylase activity and at least one altered property as compared to the parent ?-amylase, comprises i) analysing the structure of the parent Termamyl-like ?-amylase to identify at least one amino acid residue or at least one structural part of the Termamyl-like ?-amylase structure, which amino acid residue or structural part is believed to be of relevance for altering the property of the parent Termamyl-like ?-amylase (as evaluated on the basis of structural or functional considerations), ii) constructing a Termamyl-like ?-amylase variant, which as compared to the parent Termamyl-like ?-amylase, has been modified in the amino acid residue or structural part identified in i) so as to alter the property, and, optionally, iii) testing the resulting Termamyl-like ?-amylase variant with respect to the property in question.
    Type: Grant
    Filed: February 22, 2005
    Date of Patent: May 27, 2008
    Assignee: Novozymes A/S
    Inventors: Allan Svendsen, Henrik Bisgard-Frantzen, Torben Vedel Borchert
  • Patent number: 7354753
    Abstract: The invention relates to a variant of a parent fungal glucoamylase, which exhibits altered properties, in particular improved thermal stability and/or increased specific activity.
    Type: Grant
    Filed: April 23, 2003
    Date of Patent: April 8, 2008
    Assignee: Novozymes A/S
    Inventors: Bjarne Ronfeldt Nielsen, Allan Svendsen, Henrik Pedersen, Jesper Vind, Hanne Vang Hendriksen, Torben Peter Frandsen
  • Patent number: 7312062
    Abstract: The substrate specificity of a lipolytic enzyme can be modified by making alterations to the amino acid sequence in a defined region of the lipolytic enzyme, so as to increase the level of a desired activity or to decrease the level of an undesired activity. Thus, the inventors have developed lipolytic enzyme variants with a modified amino acid sequence with a substrate specificity which can be tailored for specific uses.
    Type: Grant
    Filed: November 22, 2004
    Date of Patent: December 25, 2007
    Assignee: Novozymes A/S
    Inventors: Kirsten Bojsen, Allan Svendsen, Claus Crone Fuglsang, Shamkant Anant Patkar, Kim Borch, Jesper Vind, Andreas Petri, Sanne O. Schrøder Glad, Gitte Budolfsen
  • Patent number: 7312055
    Abstract: The present invention relates to a hybrid enzyme comprising at least one carbohydrate-binding module amino acid sequence and at least the catalytic module of a glucoamylase amino acid sequence. The invention also relates to the use of the hybrid enzyme in starch processing and especially ethanol production.
    Type: Grant
    Filed: July 21, 2006
    Date of Patent: December 25, 2007
    Assignees: Novozymes A/S, Novozymes North America, Inc.
    Inventors: Torben V. Borchert, Steffen Danielsen, Eric J. Allain
  • Patent number: 7306936
    Abstract: The invention relates to a variant of a parent Termamyl-like alpha-amylase, which variant exhibits altered properties, in particular reduced capability of cleaving a substrate close to the branching point, and improved substrate specificity and/or improved specific activity relative to the parent alpha-amylase.
    Type: Grant
    Filed: May 15, 2002
    Date of Patent: December 11, 2007
    Assignee: Novozymes A/S
    Inventors: Carsten Andersen, Christel Thea Jorgensen, Henrik Bisgard-Frantzen, Allan Svendsen, Soren Kjaerulff
  • Patent number: 7282233
    Abstract: Lipolytic enzymes are chemically modified by covalently linking one or more (particularly 1-3) hydrophobic groups to the enzyme molecule. The chemical modification improves the performance of the lipolytic enzyme, e.g., in baking or in detergents.
    Type: Grant
    Filed: August 29, 2005
    Date of Patent: October 16, 2007
    Assignee: Novozymes A/S
    Inventors: Thomas Honger Callisen, Shamkant Anant Patkar, Allan Svendsen, Jesper Vind
  • Patent number: 7279315
    Abstract: The present invention relates to nucleic acids encoding polypeptides having glucanotrans-ferase activity, nucleic acid constructs, recombinant expression vectors, recombinant host cells and methods for producing polypeptides having glucanotransferase activity.
    Type: Grant
    Filed: July 14, 2003
    Date of Patent: October 9, 2007
    Assignee: Novozymes A/S
    Inventor: Shiro Fukuyama
  • Patent number: 7271139
    Abstract: The inventors have isolated novel lipolytic enzyme genes with a high homology to the T. lanuginosus lipase gene and thus well suited for use in gene shuffling. Accordingly, the invention provides a method of generating genetic diversity into lipolytic enzymes by family shuffling of two or more homologous genes which encode lipolytic enzymes. The DNA shuffling technique is used to create a library of shuffled genes, and this is expressed in a suitable expression system and the expressed proteins are screened for lipolytic enzyme activity. The invention also provides a polynucleotide comprising a nucleotide sequence encoding a lipolytic enzyme and a lipolytic enzyme (a polypeptide with lipolytic enzyme activity).
    Type: Grant
    Filed: June 23, 2006
    Date of Patent: September 18, 2007
    Assignee: Novozymes A/S
    Inventors: Noriko Tsutsumi, Jesper Vind, Shamkant Anant Patkar
  • Patent number: 7270814
    Abstract: The present invention relates to the use of a carbohydrate oxidase to reduce or prevent malodor. The present invention also relates to a deodorizing composition comprising a carbohydrate oxidase.
    Type: Grant
    Filed: June 14, 2004
    Date of Patent: September 18, 2007
    Assignee: Novozyme A/S
    Inventors: Hui Xu, Henrik Lund, Jing Luo, Kim Bloomfield
  • Patent number: 7226770
    Abstract: The properties of a fungal lipolytic enzyme can be altered by substituting amino acid residues corresponding to certain specified amino acid residues in the T. lanuginosus lipase. The altered property may be, e.g., an increased thermostability, an altered pH dependence, or an altered substrate specificity.
    Type: Grant
    Filed: April 30, 2001
    Date of Patent: June 5, 2007
    Assignee: Novozymes A/s
    Inventor: Erwin Ludo Roggen
  • Patent number: 7186427
    Abstract: The present invention relates to a method for producing a fermented dairy product including the use of an oxidase for the conversion of lactose to lactobionic acid. Moreover, it refers to a method for affecting firmness and/or sourness of a fermented dairy product. Hereby is produced a fermented dairy product having improved functional and/or organoleptic properties.
    Type: Grant
    Filed: March 29, 2005
    Date of Patent: March 6, 2007
    Assignee: Novozymes A/S
    Inventors: Gitte Budolfsen Lynglev, Rathna Koka, David W. Mehnert, Rudolf J. Fritsch
  • Patent number: 7163816
    Abstract: The present invention relates to a method of constructing a variant of a parent Termamyl-like alpha-amylase, which variant has alpha-amylase activity and at least one altered property as compared to the parent alpha-amylase, comprising i) analyzing the structure of the parent Termamyl-like alpha-amylase to identify at least one amino acid residue or at least one structural part of the Termamyl-like alpha-amylase structure, which amino acid residue or structural part is believed to be of relevance for altering the property of the parent Termamyl-like alpha-amylase (as evaluated on the basis of structural or functional considerations), ii) constructing a Termamyl-like alpha-amylase variant, which as compared to the parent Termamyl-like alpha-amylase, has been modified in the amino acid residue or structural part identified in i) so as to alter the property, and iii) testing the resulting Termamyl-like alpha-amylase variant for the property in question.
    Type: Grant
    Filed: August 26, 2004
    Date of Patent: January 16, 2007
    Assignee: Novozymes A/S
    Inventors: Allan Svendsen, Henrik Bisgaard-Frantzen, Torben Borchert
  • Patent number: 7094586
    Abstract: The present invention relates to transglutaminases and transglutaminase preparations obtained from lower fungi belonging to the class Oomycetes and unprecedented high-level expression is achievable by growing these coenocytium forming organisms, especially the strains Pythium sp., Pythium irregulare, Pythium dissotocum, Pythium periilum (or P. periplocum), Pythium torulosum, Pythium ultimum, Pythium aphanidermatum, Phytophthora cactorum, Phytophthora palmivora, Phytophthora porri, Phytophthora infestans, Phytophthora megasperma, Phytophthora cinnamomi and Phytophthora cryptogea; and a recombinant transglutaminase has been cloned and expressed, the enzyme and enzyme preparations being useful for cross-linking proteins, e.g. in flour, baked products, meat products, fish products, cosmetics, cheese, milk products, gelled food products and leather finishing, or as a glutaminase, e.g. in bread and other baked glutein-containing food products.
    Type: Grant
    Filed: June 7, 2002
    Date of Patent: August 22, 2006
    Assignee: Novozymes A/S
    Inventors: Lisbeth Bech, Grethe Rasmussen, Torben Halkier, Mariko Okada, Lene Nonboe Andersen, Markus Sakari Kauppinen, Thomas Sandal
  • Patent number: 7060468
    Abstract: The invention relates to starch conversion processes using glucoamylases derived from Talaromyces emersonii and related glucoamylases.
    Type: Grant
    Filed: July 22, 2003
    Date of Patent: June 13, 2006
    Assignee: Novozymes A/S
    Inventors: Bjarne Ronfeldt Nielsen, Ruby Ilum Nielsen, Jan Lehmbeck
  • Patent number: 7029842
    Abstract: The present invention allows the screening of previously established genebanks or libraries by proxy for genes encoding secreted, partially secreted, or cell surface-displayed polypeptides of industrial interest, such as enzymes, receptors, cytokines, peptide hormones etc. that would not likely have been isolated using conventional screening assays. A method for isolating genes encoding secreted, partially secreted, or cell surface displayed polypeptides from existing gene libraries is described in which the endogenous secretion signal sequences are detected using an in vitro polynucleotide insertion reaction where the inserted polynucleotide comprises a promoter-less and secretion signal-less secretion reporter.
    Type: Grant
    Filed: March 30, 2001
    Date of Patent: April 18, 2006
    Assignee: Novozymes A/S
    Inventors: Fiona Duffner, Reinhard Wilting, Kirk Schnorr
  • Patent number: 6960459
    Abstract: Variants of fungal cutinases having improved thermostability comprise substitution of one or more specified amino acid residues and/or a specified N-terminal extension. The variants may optionally comprise additional alterations at other positions.
    Type: Grant
    Filed: June 1, 2001
    Date of Patent: November 1, 2005
    Assignee: Novozymes A/S
    Inventors: Allan Svendsen, Sanne O. Schroder Glad, Shiro Fukuyama, Tomoko Matsui
  • Patent number: 6867031
    Abstract: The present invention relates to variants of a parent ?-amylase, which parent ?-amylase (i) has an amino acid sequence selected from the amino acid sequences shown in SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 3, and SEQ ID No.
    Type: Grant
    Filed: December 19, 2001
    Date of Patent: March 15, 2005
    Assignee: Novozymes A/S
    Inventors: Henrik Bisg{dot over (a)}rd-Frantzen, Allan Svendsen, Torben Vedel Borchert
  • Patent number: 6767701
    Abstract: A method of constructing and screening a library of polynucleotide sequences of interest in filamentous fungal cells by use of an episomal replicating AMA1-based plasmid vector, thus achieving a high frequency of transformation and a stable and standard uniformly high level of gene expression.
    Type: Grant
    Filed: October 25, 1999
    Date of Patent: July 27, 2004
    Assignee: Novozymes A/S
    Inventor: Jesper Vind
  • Patent number: RE38507
    Abstract: The staling of leavened baked products such as bread is retarded by adding an enzyme with exoamylase activity to the flour or dough used for producing the baked product in question.
    Type: Grant
    Filed: June 28, 2002
    Date of Patent: April 27, 2004
    Assignee: Novozymes A/S
    Inventor: Tine Olesen